Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...

Also likely to be on investors' minds were recent reports that Pfizer had approached GSK for merger talks, but had been rebuffed. Pfizer confirmed reports last week that it has now moved on to ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

Pfizer and Mylan have announced an all-stock ... formed a joint venture for consumer health with GlaxoSmithKline, and agreed an $11.4 billion deal to acquire cancer specialist Array BioPharma.

Now, Novartis (Swiss) and GlaxoSmithKline (British ... about whether anything can really be a merger of equals - although while AstraZeneca may be the smaller company (its $87bn market cap is less ...

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

Pfizer is raising around $3.5 billion from the sale of part of its stake in consumer-healthcare business Haleon. The pharmaceutical giant is reducing its shareholding in Haleon to 22.6% from 32% ...

The Pfizer-Wyeth merger has some worried that a wave of ... firms are planning to take the mega-merger route. London-based GlaxoSmithKline CEO Andrew Witty and Basel, Switzerland–based Novartis ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

UNILEVER has said that its future lies in health, beauty and hygiene businesses after its £50 billion bid for GSK's consumer unit ... venture with US drug giant Pfizer, but the management thinks ...

The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.